
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $164.4M | $188.5M | $245.4M | $305.2M | $363.7M | |
Revenue Growth (YoY) | 20.48% | 14.63% | 30.19% | 24.39% | 19.17% | |
Cost of Revenues | $39.9M | $44.2M | $55.1M | $65.6M | $85.7M | |
Gross Profit | $124.5M | $144.3M | $190.2M | $239.6M | $278M | |
Gross Profit Margin | 75.75% | 76.57% | 77.53% | 78.52% | 76.43% | |
R&D Expenses | $181.2M | $272.7M | $397.5M | $571M | $598.4M | |
Selling, General & Admin | $203.6M | $234.3M | $265.8M | $344.5M | $461.1M | |
Other Inc / (Exp) | $2.1M | -$28.2M | $24.4M | $15.6M | -$38.6M | |
Operating Expenses | $389.8M | $512.1M | $668.4M | $920.6M | $1.1B | |
Operating Income | -$265.2M | -$367.8M | -$478.1M | -$680.9M | -$786.6M | |
Net Interest Expenses | $29.6M | $40.5M | $26.4M | $81.7M | $84.9M | |
EBT. Incl. Unusual Items | -$292.7M | -$436.4M | -$480.2M | -$747M | -$910.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.4M | -$1.8M | $1.4M | $2.6M | $3.7M | |
Net Income to Company | -$294.1M | -$434.7M | -$481.5M | -$749.6M | -$913.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$294.1M | -$434.7M | -$481.5M | -$749.6M | -$913.8M | |
Basic EPS (Cont. Ops) | -$3.01 | -$3.88 | -$3.91 | -$5.34 | -$5.57 | |
Diluted EPS (Cont. Ops) | -$3.01 | -$3.88 | -$3.91 | -$5.34 | -$5.57 | |
Weighted Average Basic Share | $97.6M | $112.1M | $123M | $140.4M | $164M | |
Weighted Average Diluted Share | $97.6M | $112.1M | $123M | $140.4M | $164M | |
EBITDA | -$250.4M | -$383.6M | -$447.4M | -$660.2M | -$818.8M | |
EBIT | -$264.5M | -$397.8M | -$457.7M | -$670.8M | -$829.8M | |
Revenue (Reported) | $164.4M | $188.5M | $245.4M | $305.2M | $363.7M | |
Operating Income (Reported) | -$265.2M | -$367.8M | -$478.1M | -$680.9M | -$786.6M | |
Operating Income (Adjusted) | -$264.5M | -$397.8M | -$457.7M | -$670.8M | -$829.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $40.2M | $53.1M | $65.2M | $75.5M | $92.8M | |
Revenue Growth (YoY) | 9.1% | 32.06% | 22.8% | 15.77% | 22.94% | |
Cost of Revenues | $9.8M | $12.2M | $13.8M | $17.5M | $21.3M | |
Gross Profit | $30.4M | $40.9M | $51.4M | $58M | $71.5M | |
Gross Profit Margin | 75.52% | 77.05% | 78.79% | 76.88% | 77.08% | |
R&D Expenses | $61.4M | $84.4M | $127.9M | $121.1M | $152.6M | |
Selling, General & Admin | $51.6M | $56.7M | $79.9M | $93.1M | $147.5M | |
Other Inc / (Exp) | -$10K | $10.5M | $18.4M | $21.9M | -$4.3M | |
Operating Expenses | $114.2M | $142.4M | $209M | $215.4M | $301.4M | |
Operating Income | -$83.8M | -$101.5M | -$157.7M | -$157.4M | -$229.8M | |
Net Interest Expenses | $7.6M | $3.3M | $20M | $21M | $21.6M | |
EBT. Incl. Unusual Items | -$91.4M | -$94.2M | -$159.3M | -$156.5M | -$255.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $239K | $385K | $483K | $589K | $912K | |
Net Income to Company | -$91.6M | -$94.6M | -$159.8M | -$157.1M | -$256.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$91.6M | -$94.6M | -$159.8M | -$157.1M | -$256.6M | |
Basic EPS (Cont. Ops) | -$0.89 | -$0.80 | -$1.17 | -$1.06 | -$1.42 | |
Diluted EPS (Cont. Ops) | -$0.89 | -$0.80 | -$1.17 | -$1.06 | -$1.42 | |
Weighted Average Basic Share | $103M | $118.9M | $136.4M | $148.5M | $180.9M | |
Weighted Average Diluted Share | $103M | $118.9M | $136.4M | $148.5M | $180.9M | |
EBITDA | -$80.5M | -$89.2M | -$138.4M | -$133.7M | -$232.8M | |
EBIT | -$84.2M | -$91.8M | -$140.9M | -$136.6M | -$235.9M | |
Revenue (Reported) | $40.2M | $53.1M | $65.2M | $75.5M | $92.8M | |
Operating Income (Reported) | -$83.8M | -$101.5M | -$157.7M | -$157.4M | -$229.8M | |
Operating Income (Adjusted) | -$84.2M | -$91.8M | -$140.9M | -$136.6M | -$235.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $167.8M | $201.4M | $257.5M | $315.5M | $381M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $41.3M | $46.5M | $56.8M | $69.2M | $89.6M | |
Gross Profit | $126.5M | $154.9M | $200.7M | $246.3M | $291.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $206.4M | $295.7M | $441M | $564.2M | $629.9M | |
Selling, General & Admin | $203.8M | $239.5M | $289M | $357.7M | $515.6M | |
Other Inc / (Exp) | $658K | -$17.7M | $32.3M | $19.2M | -$64.8M | |
Operating Expenses | $415.2M | $540.2M | $735M | $927M | $1.2B | |
Operating Income | -$288.7M | -$385.4M | -$534.3M | -$680.7M | -$859M | |
Net Interest Expenses | $29.7M | $36.2M | $43.2M | $82.7M | $85.4M | |
EBT. Incl. Unusual Items | -$317.8M | -$439.2M | -$545.2M | -$744.2M | -$1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.6M | -$1.6M | $1.5M | $2.7M | $4M | |
Net Income to Company | -$319.4M | -$437.6M | -$546.7M | -$746.9M | -$1B | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$319.4M | -$437.6M | -$546.7M | -$746.9M | -$1B | |
Basic EPS (Cont. Ops) | -$3.16 | -$3.78 | -$4.27 | -$5.23 | -$5.95 | |
Diluted EPS (Cont. Ops) | -$3.16 | -$3.78 | -$4.27 | -$5.23 | -$5.95 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$275.2M | -$393.1M | -$496.6M | -$655.5M | -$917.9M | |
EBIT | -$289.4M | -$406.2M | -$506.9M | -$666.4M | -$929.2M | |
Revenue (Reported) | $167.8M | $201.4M | $257.5M | $315.5M | $381M | |
Operating Income (Reported) | -$288.7M | -$385.4M | -$534.3M | -$680.7M | -$859M | |
Operating Income (Adjusted) | -$289.4M | -$406.2M | -$506.9M | -$666.4M | -$929.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $40.2M | $53.1M | $65.2M | $75.5M | $92.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.8M | $12.2M | $13.8M | $17.5M | $21.3M | |
Gross Profit | $30.4M | $40.9M | $51.4M | $58M | $71.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $61.4M | $84.4M | $127.9M | $121.1M | $152.6M | |
Selling, General & Admin | $51.6M | $56.7M | $79.9M | $93.1M | $147.5M | |
Other Inc / (Exp) | -$10K | $10.5M | $18.4M | $21.9M | -$4.3M | |
Operating Expenses | $114.2M | $142.4M | $209M | $215.4M | $301.4M | |
Operating Income | -$83.8M | -$101.5M | -$157.7M | -$157.4M | -$229.8M | |
Net Interest Expenses | $7.6M | $3.3M | $20M | $21M | $21.6M | |
EBT. Incl. Unusual Items | -$91.4M | -$94.2M | -$159.3M | -$156.5M | -$255.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $239K | $385K | $483K | $589K | $912K | |
Net Income to Company | -$91.6M | -$94.6M | -$159.8M | -$157.1M | -$256.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$91.6M | -$94.6M | -$159.8M | -$157.1M | -$256.6M | |
Basic EPS (Cont. Ops) | -$0.89 | -$0.80 | -$1.17 | -$1.06 | -$1.42 | |
Diluted EPS (Cont. Ops) | -$0.89 | -$0.80 | -$1.17 | -$1.06 | -$1.42 | |
Weighted Average Basic Share | $103M | $118.9M | $136.4M | $148.5M | $180.9M | |
Weighted Average Diluted Share | $103M | $118.9M | $136.4M | $148.5M | $180.9M | |
EBITDA | -$80.5M | -$89.2M | -$138.4M | -$133.7M | -$232.8M | |
EBIT | -$84.2M | -$91.8M | -$140.9M | -$136.6M | -$235.9M | |
Revenue (Reported) | $40.2M | $53.1M | $65.2M | $75.5M | $92.8M | |
Operating Income (Reported) | -$83.8M | -$101.5M | -$157.7M | -$157.4M | -$229.8M | |
Operating Income (Adjusted) | -$84.2M | -$91.8M | -$140.9M | -$136.6M | -$235.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $532.8M | $716.8M | $1.1B | $482.4M | $555M | |
Short Term Investments | -- | -- | $74.2M | $298.1M | $878.8M | |
Accounts Receivable, Net | $16.6M | $24.4M | $29.7M | $41.2M | $52M | |
Inventory | $49.6M | $67M | $69.9M | $83.2M | $98.6M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $24M | $28.9M | $25.5M | $24.2M | $37.2M | |
Total Current Assets | $622.9M | $837M | $1.3B | $929.1M | $1.6B | |
Property Plant And Equipment | $97.2M | $95.5M | $102.1M | $104.4M | $115.6M | |
Long-Term Investments | -- | $50M | -- | -- | -- | |
Goodwill | -- | $136.1M | $136.1M | $136.1M | $136.1M | |
Other Intangibles | $49.3M | $73.8M | $68.8M | $63.7M | $58.7M | |
Other Long-Term Assets | $26.8M | $51M | $76.1M | $96.6M | $93.2M | |
Total Assets | $796.2M | $1.2B | $1.7B | $1.3B | $2B | |
Accounts Payable | $42.9M | $35.8M | $50.5M | $65.4M | $73M | |
Accrued Expenses | $34.4M | $49.1M | $82.1M | $84.9M | $96.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $12.6M | $10.1M | $8.1M | $10.6M | $12.3M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $118.8M | $135.2M | $190.2M | $225.6M | $297.5M | |
Long-Term Debt | $356.3M | $566.6M | $1.1B | $1.2B | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $520.3M | $833M | $1.6B | $1.7B | $1.7B | |
Common Stock | $1M | $1.2M | $1.4M | $1.5M | $1.8M | |
Other Common Equity Adj | $193K | $968K | $756K | -$745K | -$2.3M | |
Common Equity | $275.9M | $410.5M | $88M | -$331.9M | $285.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $275.9M | $410.5M | $88M | -$331.9M | $285.4M | |
Total Liabilities and Equity | $796.2M | $1.2B | $1.7B | $1.3B | $2B | |
Cash and Short Terms | $532.8M | $716.8M | $1.1B | $780.4M | $1.4B | |
Total Debt | $356.3M | $566.6M | $1.1B | $1.2B | $1.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $409.8M | $515.7M | $968.9M | $595.7M | $403.2M | |
Short Term Investments | -- | $119.4M | $29.8M | -- | $796.2M | |
Accounts Receivable, Net | $17.6M | $25.7M | $30.5M | $37.2M | $47.7M | |
Inventory | $52.1M | $64.1M | $71.3M | $83M | $100.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $21.6M | $31.2M | $28.5M | $42.9M | $54.8M | |
Total Current Assets | $501M | $756.1M | $1.1B | $758.7M | $1.4B | |
Property Plant And Equipment | $97M | $101.8M | $103.7M | $106.1M | $116.8M | |
Long-Term Investments | -- | $29.6M | -- | -- | -- | |
Goodwill | -- | $136.1M | $136.1M | $136.1M | $136.1M | |
Other Intangibles | $48M | $72.5M | $67.5M | $62.4M | $57.4M | |
Other Long-Term Assets | $46.4M | $57.2M | $81.3M | $95.7M | $89.8M | |
Total Assets | $692.4M | $1.2B | $1.5B | $1.2B | $1.8B | |
Accounts Payable | $22.4M | $48.6M | $56.7M | $44M | $57.7M | |
Accrued Expenses | $37.9M | $42.5M | $80.4M | $99.3M | $102.5M | |
Current Portion Of Long-Term Debt | -- | -- | -- | $224.2M | -- | |
Current Portion Of Capital Lease Obligations | $7.5M | $9.8M | $9M | $7.3M | $6.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $81.4M | $125.2M | $188M | $420.9M | $239.2M | |
Long-Term Debt | $361.6M | $783.2M | $1.1B | $939.1M | $1.1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $490.8M | $1B | $1.6B | $1.6B | $1.7B | |
Common Stock | $1M | $1.2M | $1.4M | $1.5M | $1.8M | |
Other Common Equity Adj | $90K | -$230K | $1.1M | -$1.6M | -$902K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $201.6M | $119.9M | -$44.7M | -$464.8M | $99.2M | |
Total Liabilities and Equity | $692.4M | $1.2B | $1.5B | $1.2B | $1.8B | |
Cash and Short Terms | $409.8M | $635.1M | $998.7M | $595.7M | $1.2B | |
Total Debt | $361.6M | $783.2M | $1.1B | $1.2B | $1.1B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$294.1M | -$434.7M | -$481.5M | -$749.6M | -$913.8M | |
Depreciation & Amoritzation | $14.2M | $14.2M | $10.3M | $10.6M | $11M | |
Stock-Based Compensation | $36.2M | $46M | $57.7M | $74.8M | $96.8M | |
Change in Accounts Receivable | $2.7M | -$8.1M | -$6.4M | -$12M | -$12.9M | |
Change in Inventories | -$21.2M | -$17.5M | -$1.7M | -$13.6M | -$17M | |
Cash From Operations | -$219.3M | -$363.3M | -$400.4M | -$536.2M | -$683.9M | |
Capital Expenditures | $6.8M | $7.3M | $9.9M | $13.3M | $21.9M | |
Cash Acquisitions | -- | -$6.7M | -- | -- | -- | |
Cash From Investing | -$6.8M | -$64.3M | -$34.6M | -$223.6M | -$583.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | $575M | $350M | -- | $150M | |
Long-Term Debt Repaid | -- | -$238.7M | -$601K | -$1.2M | -$2.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$936K | -$15.7M | $132.2M | -$1.2M | -$3.7M | |
Cash From Financing | $271M | $612.5M | $793.3M | $168.4M | $1.3B | |
Beginning Cash (CF) | $487.4M | $532.8M | $716.8M | $1.1B | $482.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $44.8M | $185M | $358.3M | -$591.4M | $74M | |
Ending Cash (CF) | $532.8M | $716.8M | $1.1B | $482.4M | $555M | |
Levered Free Cash Flow | -$226.2M | -$370.6M | -$410.3M | -$549.5M | -$705.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$91.6M | -$94.6M | -$159.8M | -$157.1M | -$256.6M | |
Depreciation & Amoritzation | $3.7M | $2.5M | $2.5M | $2.9M | $3.1M | |
Stock-Based Compensation | $10.5M | $12.8M | $16.4M | $21.5M | $39.3M | |
Change in Accounts Receivable | -$1.1M | -$1.8M | -$860K | $3M | $5.4M | |
Change in Inventories | -$2.8M | $2.2M | -$1.2M | -$598K | -$1M | |
Cash From Operations | -$128.3M | -$105.2M | -$146.3M | -$184M | -$262.1M | |
Capital Expenditures | $1.2M | $1.7M | $3.4M | $4.7M | $10.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.2M | -$101.4M | $41.6M | $295.3M | $80.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$258K | -$359K | -$320K | -$621K | -$706K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1.2M | -$409K | -- | |
Cash From Financing | $6.7M | $6.5M | -$399K | $3M | $29M | |
Beginning Cash (CF) | $532.8M | $716.8M | $1.1B | $482.4M | $555M | |
Foreign Exchange Rate Adjustment | -$246K | -$969K | -$29K | -$953K | $895K | |
Additions / Reductions | -$122.8M | -$200.1M | -$105.1M | $114.3M | -$152.7M | |
Ending Cash (CF) | $409.8M | $515.7M | $968.9M | $595.7M | $403.2M | |
Levered Free Cash Flow | -$129.5M | -$106.9M | -$149.7M | -$188.7M | -$272.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$319.4M | -$437.6M | -$546.7M | -$746.9M | -$1B | |
Depreciation & Amoritzation | $14.3M | $13.1M | $10.3M | $10.9M | $11.3M | |
Stock-Based Compensation | $37.7M | $48.3M | $61.3M | $79.8M | $114.6M | |
Change in Accounts Receivable | -$474K | -$8.9M | -$5.5M | -$8.1M | -$10.5M | |
Change in Inventories | -$21.6M | -$12.5M | -$5.1M | -$13M | -$17.5M | |
Cash From Operations | -$289.7M | -$340.2M | -$441.6M | -$574M | -$761.9M | |
Capital Expenditures | $5.3M | $7.8M | $11.6M | $14.6M | $27.3M | |
Cash Acquisitions | -- | -$6.7M | -- | -- | -- | |
Cash From Investing | -$5.3M | -$164.5M | $108.4M | $30.1M | -$798.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | $34K | -$238.8M | -$562K | -$1.5M | -$2.7M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$409K | -- | |
Cash From Financing | $275.6M | $612.3M | $786.4M | $171.9M | $1.4B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$19.4M | $107.6M | $453.3M | -$372M | -$193M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$295M | -$348M | -$453.2M | -$588.5M | -$789.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$91.6M | -$94.6M | -$159.8M | -$157.1M | -$256.6M | |
Depreciation & Amoritzation | $3.7M | $2.5M | $2.5M | $2.9M | $3.1M | |
Stock-Based Compensation | $10.5M | $12.8M | $16.4M | $21.5M | $39.3M | |
Change in Accounts Receivable | -$1.1M | -$1.8M | -$860K | $3M | $5.4M | |
Change in Inventories | -$2.8M | $2.2M | -$1.2M | -$598K | -$1M | |
Cash From Operations | -$128.3M | -$105.2M | -$146.3M | -$184M | -$262.1M | |
Capital Expenditures | $1.2M | $1.7M | $3.4M | $4.7M | $10.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.2M | -$101.4M | $41.6M | $295.3M | $80.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$258K | -$359K | -$320K | -$621K | -$706K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1.2M | -$409K | -- | |
Cash From Financing | $6.7M | $6.5M | -$399K | $3M | $29M | |
Beginning Cash (CF) | $532.8M | $716.8M | $1.1B | $482.4M | $555M | |
Foreign Exchange Rate Adjustment | -$246K | -$969K | -$29K | -$953K | $895K | |
Additions / Reductions | -$122.8M | -$200.1M | -$105.1M | $114.3M | -$152.7M | |
Ending Cash (CF) | $409.8M | $515.7M | $968.9M | $595.7M | $403.2M | |
Levered Free Cash Flow | -$129.5M | -$106.9M | -$149.7M | -$188.7M | -$272.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.